- Home
- RLAY vs RBA Comparison
RLAY vs RBA Comparison
Compare RLAY & RBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- RBA
- Stock Information
- Founded
- RLAY 2015
- RBA 1958
- Country
- RLAY United States
- RBA United States
- Employees
- RLAY N/A
- RBA N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- RBA Business Services
- Sector
- RLAY Health Care
- RBA Consumer Discretionary
- Exchange
- RLAY Nasdaq
- RBA Nasdaq
- Market Cap
- RLAY 576.1M
- RBA 19.7B
- IPO Year
- RLAY 2020
- RBA 1998
- Fundamental
- Price
- RLAY $3.60
- RBA $107.97
- Analyst Decision
- RLAY Strong Buy
- RBA Buy
- Analyst Count
- RLAY 11
- RBA 6
- Target Price
- RLAY $18.40
- RBA $111.42
- AVG Volume (30 Days)
- RLAY 1.6M
- RBA 938.2K
- Earning Date
- RLAY 08-05-2025
- RBA 08-06-2025
- Dividend Yield
- RLAY N/A
- RBA 1.08%
- EPS Growth
- RLAY N/A
- RBA 22.04
- EPS
- RLAY N/A
- RBA 2.03
- Revenue
- RLAY $7,679,000.00
- RBA $4,328,100,000.00
- Revenue This Year
- RLAY $17.59
- RBA $4.62
- Revenue Next Year
- RLAY N/A
- RBA $4.06
- P/E Ratio
- RLAY N/A
- RBA $53.27
- Revenue Growth
- RLAY N/A
- RBA 2.27
- 52 Week Low
- RLAY $1.78
- RBA $70.38
- 52 Week High
- RLAY $10.72
- RBA $109.25
- Technical
- Relative Strength Index (RSI)
- RLAY 57.25
- RBA 63.00
- Support Level
- RLAY $3.50
- RBA $103.56
- Resistance Level
- RLAY $3.86
- RBA $105.97
- Average True Range (ATR)
- RLAY 0.18
- RBA 1.83
- MACD
- RLAY 0.02
- RBA 0.18
- Stochastic Oscillator
- RLAY 65.79
- RBA 91.23
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About RBA RB Global Inc.
RB Global operates the world's largest auction for heavy equipment. The company started as a live auctioneer of industrial equipment; since then it has greatly expanded its operations to include the sale of construction, agricultural, oilfield, and transportation equipment. RB Global operates over 40 live auction sites in more than 12 countries, along with online marketplaces, including IronPlanet, Marketplace-E, and GovPlanet. Its agricultural auctions are frequently much smaller venues and can include liquidations of single farms. The company holds over 300 auctions yearly and sells $6 billion worth of equipment.